Pharmachemie B.V. v. Barr Laboratories, Inc.
284 F.3d 125, 350 U.S. App. D.C. 290, 2002 U.S. App. LEXIS 9162, 2002 WL 431838
Court of Appeals for the D.C. Circuit·Decided March 20, 2002·No. Nos. 00-5206, 00-5207·Published·Cited by 3 cases
Opinion
ORDER
For the reasons set forth in the court’s opinion dated January 18, 2002, in the consolidated matter of Pharmachemie, B.V. v. Barr Laboratories, Inc., No. 00-5206, it is
ORDERED that appeal No. 00-5207, Mylan Pharmaceuticals, Inc. v. Barr Laboratories, Inc., be dismissed as moot, the judgment of the district court be vacated, and the case remanded to the district court with instructions to dismiss Mylan’s complaint.
Free access — add to your briefcase to read the full text and ask questions with AI
Pharmachemie B.V. v. Barr Laboratories, Inc., 284 F.3d 125, 350 U.S. App. D.C. 290, 2002 U.S. App. LEXIS 9162, 2002 WL 431838 (D.C. Cir. 2002).
284 F.3d 125 (Pharmachemie B.V. v. Barr Laboratories, Inc.) — published by Counsel Stack Legal Research, free access to 12M+ legal documents.
Related
In Re Tamoxifen Citrate Antitrust Litigation
429 F.3d 370 (Second Circuit, 2005)
Joblove, Allied Servs. v. Barr Labs. Inc.
429 F.3d 370 (Second Circuit, 2005)
Joblove v. Barr Labs. Inc.
466 F.3d 187 (Second Circuit, 2005)